about
Lentiviral protein transduction with genome-modifying HIV-1 integrase-I-PpoI fusion proteins: studies on specificity and cytotoxicityDistinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.Genetic variation and HIV-associated neurologic disease.Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR.The human antiviral factor TRIM11 is under the regulation of HIV-1 Vpr.The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domainsHIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis.Impact of the Ku complex on HIV-1 expression and latency.Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localizationNef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes.Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.Host restriction factors in retroviral infection: promises in virus-host interaction.A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic developmentAn HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.Binding of HIV-1 Vpr protein to the human homolog of the yeast DNA repair protein RAD23 (hHR23A) requires its xeroderma pigmentosum complementation group C binding (XPCB) domain as well as the ubiquitin-associated 2 (UBA2) domain.Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.Recent patents and emerging therapeutics for HIV infections: a focus on protease inhibitors.HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies.rDNA-directed integration by an HIV-1 integrase--I-PpoI fusion proteinYeast for virus researchMyeloid Dendritic Cells Induce HIV Latency in Proliferating CD4 T Cells
P2860
Q33594311-EEBED979-E86A-4D3B-9AB4-E99087859F96Q33791156-CEDFD49B-7C47-48BF-902B-98616959EDCFQ33819189-9B742FBE-5ACA-4506-826B-74DDE1B9B058Q33831542-7FF6DCE6-F019-4227-B52E-8B41DB690587Q34020546-7F8222F3-43C8-4727-8C1E-08EA0D87E4D4Q34106660-400D4E9A-EAE7-4578-A714-A8E6451424A4Q34848256-F8476483-17DA-421F-AE05-7F2F03D4AA2EQ34903532-98A2B00A-5FD3-4065-B373-8261A1B52EABQ35200604-61910D14-4816-4021-92F8-5390BBB3931CQ36112824-58D9B278-4EC8-4F1D-B359-DE9524020AA9Q36484010-257A094C-9BFB-4192-92A4-0983A74E0109Q36548179-8777A8BF-A5F6-48FC-B0C2-6542ADFAE87DQ36553297-E0644657-FC3C-477D-8A10-7202A9ACC0F5Q37127522-28A1D271-2D36-4A88-BFCF-F65AC6D75DD6Q37336473-3BE08271-9CBC-40D9-AA39-0C930BB85B44Q37536456-9A421439-5E9C-4663-A303-60EF37168587Q37932423-07BEAD04-78A3-4011-9748-E0135E6BD9E1Q38162985-E891DFF6-35F3-4DEF-9855-0BDBA9D46D80Q38855423-6C840DA4-3B31-4AB8-ADFB-1768966F2545Q41124443-2974DC7D-EA7B-4853-A64A-AC2DA5600553Q42624207-E3C0AAB5-3241-4127-86C6-5017745C14ABQ58003754-0AD56473-5A0D-4612-8EA4-295FBCB4C583
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vpr-host interactions during HIV-1 viral life cycle.
@ast
Vpr-host interactions during HIV-1 viral life cycle.
@en
type
label
Vpr-host interactions during HIV-1 viral life cycle.
@ast
Vpr-host interactions during HIV-1 viral life cycle.
@en
prefLabel
Vpr-host interactions during HIV-1 viral life cycle.
@ast
Vpr-host interactions during HIV-1 viral life cycle.
@en
P2860
P1476
Vpr-host interactions during HIV-1 viral life cycle.
@en
P2093
Michael I Bukrinsky
P2860
P2888
P304
P356
10.1007/S11481-011-9261-Z
P577
2011-02-12T00:00:00Z
P5875
P6179
1028261161